Information for Health Professionals

ASCIA develops Clinical Updates, Action/Treatment Plans, Checklists, Position Papers/Statements, Guidelines and e-training courses for health professionals.  

Quick links for this page

Allergic Rhinitis

• ASCIA Clinical Update - Allergic Rhinitis New September 2017
• ASCIA Treatment Plan - Allergic Rhinitis Updated September 2017
• ASCIA Allergic Rhinitis e-training for health professionals
  
• ASCIA Allergic Rhinitis e-training for pharmacists 
• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols New November 2018

Anaphylaxis

• ASCIA Guidelines - Acute management of anaphylaxis Updated  December 2018
• ASCIA Guidelines - Adrenaline (epinephrine) autoinjector prescription
• ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update
• ASCIA Anaphylaxis Resources Overview   
  
• ASCIA Clinical Update - Anaphylaxis 
  
• ASCIA Checklists - Anaphylaxis
• ASCIA Event record for allergic reactions
• ASCIA Checklist - Transitioning patients from paediatric to adult services
• ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis
• ASCIA Anaphylaxis e-training for health professionals 
  
• ASCIA Anaphylaxis e-training for pharmacists 
  

Drug allergy

• ASCIA Clinical Update - Antibiotic Allergy
• ASCIA Consensus Statement - Penicillin Allergy (available to Members only)
• ASCIA Drug allergy pre-clinic information template (available to Members only)
• ASCIA Penicillin Allergy Guide for health professionals 
• ASCIA Penicillin Allergy etraining for health professionals 
  (https://etraininghp.ascia.org.au/penicillin-allergy) New December 2018

Food allergy

• ASCIA Clinical Updates - Food Allergy Under Review 
• ASCIA Dietary avoidance information sheets 
• ASCIA Information HP - Lupin Allergy
• ASCIA Food Allergy e-training for health professionals 
  
• ASCIA Food Allergy e-training for pharmacists 
  
• ASCIA Food Allergen Challenge Protocols (available to Members only)

Immunodeficiency

• Immunodeficiency Overview 
  
• ASCIA Position Paper - Hereditary Angioedema (HAE) 
  
• ASCIA Clinical Update - Primary Immunodeficiencies (PID) 
  
• ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg) Updated June 2018
• ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital Updated January 2019 
• ASCIA Guidelines for standardised IVIg infusion rates for IRT Updated June 2018 
• ASCIA SCIg Treatment Plan New August 2017 
• ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) New June 2018
• ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy  Updated January 2019

Immunisation

• ASCIA Guidelines - vaccination of the egg allergic individual 

Allergen Immunotherapy

• ASCIA Manual – Allergen Immunotherapy (available to Members only)
• ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT)
• ASCIA Immunotherapy e-training for health professionals 

Infant feeding and allergy prevention

• Overview - Infant feeding and allergy prevention
• ASCIA Clinical Update Infant Feeding and Allergy Prevention
• ASCIA Guidelines - Infant feeding and allergy prevention 
• ASCIA Guide: stepwise management of eczema (atopic dermatitis) management 
• ASCIA Information on how to introduce solid foods to babies for allergy prevention Updated May 2018
• ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy 

Insect allergy      

• ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
• ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem

Latex allergy

• ASCIA Guidelines - Management of Latex-Allergic Individuals

Skin

• ASCIA Action Plan for Eczema
• ASCIA Guide to eczema (atopic dermatitis) management  New September 2018
  
• ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
• ASCIA Guidelines - Chronic Spontaneous Urticaria (CSU)

Tests

• ASCIA Food Allergen Challenge Protocols (available to Members only)
• ASCIA Position Statement - Unorthodox Techniques for the Diagnosis and Treatment of Allergy, Asthma and Immune Disorders
• Allergy treatment declared misleading
• Testing for IgG4 against foods is not recommended as a diagnostic tool
• Vega Testing in the Diagnosis of Allergic Conditions
  
• ASCIA Manual - Skin Prick Testing for Allergy Diagnosis
• ASCIA Guidelines - Anti-Intrinsic Factor Antibody Testing
• ASCIA Guidelines - Uncertainty of Measurement 
• Laboratory Tests in the Diagnosis of Allergic Diseases 
• Unorthodox Testing and Treatment for Allergic Disorders

External documents

• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
• Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
• Australian Prescriber Anaphylaxis Wall Chart
• Australian Academy of Science - The science of immunisation
• APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency 
• Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
• European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool 

For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information

Content updated January 2019